Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
The cybersecurity company returned to public markets Thursday in the first big U.S. technology listing of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback